Evidence map›Paper›PMID 23778871›Full record

ArticleEuropean journal of human genetics : EJHG2014

A MEN1 syndrome with a paraganglioma.

Yvan Jamilloux, Judith Favier, Morgane Pertuit, Manuela Delage-Corre, Stéphanie Lopez, Marie-Pierre Teissier, Muriel Mathonnet, Sophie Galinat, Anne Barlier, Françoise Archambeaud

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in European journal of human genetics : EJHG, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Non-Susceptibility Gene Variants in Head and Neck Paragangliomas.International journal of molecular sciences · 2024
    Article
  4. Article
  5. Article
  6. 18F-FDOPA PET/CT accurately identifies MEN1-associated pheochromocytoma.Endocrinology, diabetes & metabolism case reports · 2020
    Article
  7. Coexistence of DIPNECH and carotid body paraganglioma: is it just a coincidence?Endocrinology, diabetes & metabolism case reports · 2020
    Article
  8. The 3PAs: An Update on the Association of Pheochromocytomas, Paragangliomas, and Pituitary Tumors.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2019
    Review
  9. Review
  10. Exome analysis of carotid body tumor.BMC medical genomics · 2018
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Yvan Jamilloux1] Department of Internal Medicine A, University Hospital of Limoges, Limoges, France [2] Department of Internal Medicine B, Endocrinology and Metabolic Diseases, University Hospital of Limoges, Limoges, France.
Judith Favier1] INSERM, UMR970, Paris Cardiovascular Research Center at HEGP, Paris, France [2] Medicine Faculty, University of Paris Descartes, Paris, France.
Morgane PertuitAPHM - Conception, Laboratory of Molecular Biology, Aix-Marseille University, Marseille, France.
Manuela Delage-CorreDepartment of Pathology, University Hospital of Limoges, Limoges, France.
Stéphanie LopezDepartment of Internal Medicine B, Endocrinology and Metabolic Diseases, University Hospital of Limoges, Limoges, France.
Marie-Pierre TeissierDepartment of Internal Medicine B, Endocrinology and Metabolic Diseases, University Hospital of Limoges, Limoges, France.
Muriel MathonnetDepartment of Surgery, University Hospital of Limoges, Limoges, France.
Sophie GalinatDepartment of Internal Medicine B, Endocrinology and Metabolic Diseases, University Hospital of Limoges, Limoges, France.
Anne BarlierAPHM - Conception, Laboratory of Molecular Biology, Aix-Marseille University, Marseille, France.
Françoise ArchambeaudDepartment of Internal Medicine B, Endocrinology and Metabolic Diseases, University Hospital of Limoges, Limoges, France.
Université de Limoges · FRAix-Marseille Université · FRParis Cardiovascular Research Center · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Germline mutations of the MEN1 gene cause multiple endocrine neoplasia type 1 (MEN1), an autosomal dominant disorder characterized by tumors of the parathyroids, the pancreas, and the anterior pituitary. Paraganglioma (PGL) is a rare endocrine tumor, which can be sporadic or genetically determined. To date, PGL has never been reported as a feature of MEN1.We report here a patient presenting three features of MEN1 syndrome (hyperparathyroidism, pancreatic neuroendocrine tumor, and adrenocortical adenoma) associated with PGL. Genetic analysis of MEN1 gene revealed a new missense mutation in exon 5 (AGGAAG), causing the substitution of arginine by lysine at codon 275. Screening for other genetic disorders (SDHx, TMEM127, MAX, CDKN1B) causing PGL was negative. Immunohistochemical analyses showed normal levels of succinate dehydrogenase (SDH)A and SDHB in the PGL. The proband's sister, bearing the mutation, had primary hyperparathyroidism. It was the first typical MEN1 syndrome reported with an extra-adrenal PGL.

Indexed as

Abnormalities, MultipleAdrenal Cortex NeoplasmsDNA Mutational AnalysisFemaleHumansMutation, MissensePancreatic NeoplasmsParagangliomaPedigreeProto-Oncogene ProteinsRadiographySyndromeMEN1 protein, humanProto-Oncogene Proteins

Identifiers

PMID23778871
PMCPMC3895646
OpenAlexW2088147435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.